X0206 3 2013-05-21 0 0001269021 PORTOLA PHARMACEUTICALS INC PTLA 0001187333 RENTON HOLLINGS C/O PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 9.00 2020-04-27 Common Stock 20000 D Stock Option (Right to Buy) 7.00 2021-12-14 Common Stock 5000 D Stock Option (Right to Buy) 7.00 2021-12-14 Common Stock 520 D Stock Option (Right to Buy) 7.00 2022-09-24 Common Stock 5000 D Series D Convertible Preferred Stock Common Stock 2826 I By the Renton Family Community Property Trust The Option shares shall vest as follows: 1/24th of the shares subject to such option shall vest each month after April 29, 2010, subject to Reporting Person's Continuous Service ( as defined in the Issuer's 2003 Equity Incentive Plan) as of each such date. The Option shares shall vest as follows: 1/24th of the shares subject to such option shall vest each month after September 22, 2011, subject to Reporting Person's Continuous Service ( as defined in the Issuer's 2003 Equity Incentive Plan) as of each such date. The Option is fully vested as of December 15, 2011. The Option shares shall vest as follows: 50% of the shares vest one year after September 1, 2012; the balance of the shares vest in a series of twelve (12) successive equal monthly installments measured from the first anniversary of September 1, 2012, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2003 Equity Incentive Plan) as of each such date. The Series D Preferred Stock has no expiration date and is convertible at any time at the option of the holder and will automatically convert upon the closing of the Issuer's initial public offering, at a conversion ratio of 1 share of Common Stock for every 1 share of Series D Preferred Stock, for no additional consideration. The shares do not have an expiration date. /s/ Sally A. Kay, as attorney-in-fact 2013-05-21